Business Context and Reporting Period
This Form 6-K filing by InflaRx N.V. covers the month of April 2022. The registrant is a foreign private issuer based in Jena, Germany. The filing serves to notify shareholders of the convening of the Annual General Meeting scheduled for April 28, 2022, and to provide access to related meeting materials.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document focuses solely on corporate governance activities related to the upcoming Annual General Meeting.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It references attached exhibits (Convening Notice and Voting Proxy) which may contain additional details, but the summary text itself is limited to the announcement of the meeting.
Investor Verification Checklist
- Verify the date and agenda of the Annual General Meeting scheduled for April 28, 2022.
- Review the attached Exhibit 99.1 (Convening Notice) for specific resolutions to be voted upon.
- Confirm the availability of the Voting Proxy (Exhibit 99.2) for shareholders unable to attend in person.
- Note that this filing does not include financial results; refer to the most recent Form 20-F for financial data.